Mandibular hypoplasia, deafness, and progeroid features, with concomitant lipodystrophy, define a multisystem disorder named MDPL syndrome. MDPL has been associated with heterozygous mutations in POLD1 gene resulting in loss of DNA polymerase δ activity. In this study, we report clinical, genetic, and cellular studies of a 13-year-old Pakistani girl, presenting growth retardation, sensorineural deafness, altered distribution of subcutaneous adipose tissue, and insulin resistance. We performed Sanger sequencing of POLD1 gene in the proband and the healthy parents. Fibroblasts obtained from dermal biopsy were evaluated for the specific hallmarks of cellular senescence and for their response to the DNA-induced damage. Patient carried the recurrent heterozygous de novo in frame deletion (c.1812_1814delCTC, p.Ser605del) within POLD1 gene, previously detected in 16 MDPL patients. In patient's fibroblasts we observed severe nuclear envelope anomalies, presence of micronuclei, accumulation of prelamin A, altered cell growth, and cellular senescence. In addition, we observed a persistence of DNA damage after cisplatin exposure, compared to control cells. In conclusion, the MDPL nuclear and cellular findings resemble features observed in other progeroid syndromes and familial lipodystrophies. Although further investigations will be necessary, these information could be used to establish targeted therapeutic approaches.
Get full access to this article
View all access options for this article.
References
1.
AdelfalkC., ScherthanH., Hirsch-KauffmannM., and SchweigerM. (2005). Nuclear deformation characterizes Werner syndrome cells. Cell Biol Int, 29, 1032–1037.
2.
AgarwalA.K., FrynsJ.P., AuchusR.J., and GargA. (2003). Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet, 12, 1995–2001.
3.
AjluniN., MeralR., NeidertA.H., BradyG.F., BurasE., McKennaB., et al. (2017). Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort. Clin Endocrinol (Oxf), 86, 698–707.
4.
AroraS., YanH., ChoI., FanH.Y., LuoB., GaiX., et al. (2015). Genetic variants that predispose to DNA double-strand breaks in lymphocytes from a subset of patients with familial colorectal carcinomas. Gastroenterology, 149, 1872–1883.
5.
ChenT., LiM., WuH., XieR., WangF., ChenX., et al. (2017). Short stature as the first manifestation of mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome. Int J Clin Exp Med, 10, 3876–3883.
6.
Debacq-ChainiauxF., ErusalimskyJ.D., CampisiJ., and ToussaintO. (2009). Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc, 4, 1798–1806.
7.
ElouejS., Beleza-MeirelesA., CaswellR., ColcloughK., EllardS., DesvignesJ.P., et al. (2017). Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL). Metabolism, 71, 213–225.
8.
HussainI., and GargA. (2016). Lipodystrophy syndromes. Endocrinol Metab Clin North Am, 45, 783–797.
9.
Kamath-LoebA.S., ShenJ.C., SchmittM.W., and LoebL.A. (2012). The Werner syndrome exonuclease facilitates DNA degradation and high fidelity DNA polymerization by human DNA polymerase delta. J Biol Chem, 287, 12480–12490.
10.
LesselD., HisamaF.M., SzakszonK., SahaB., SanjuaneloA.B., SalbertB.A., et al. (2015). POLD1 germline mutations in patients initially diagnosed with Werner syndrome. Hum Mutat, 36, 1070–1079.
11.
NicolasE., GolemisE.A., and AroraS. (2016). POLD1: central mediator of DNA replication and repair, and implication in cancer and other pathologies. Gene, 590, 128–141.
12.
NovelliG., MuchirA., SangiuoloF., Helbling-LeclercA., D'ApiceM.R., MassartC., et al. (2002). Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet, 71, 426–431.
13.
OkadaA., KohmotoT., NarutoT., YokotaI., KotaniY., ShimadaA., et al. (2017). The first Japanese patient with mandibular hypoplasia, deafness, progeroid features and lipodystrophy diagnosed via POLD1 mutation detection. Hum Genome Var 4,17031.
14.
PallesC., CazierJ.B., HowarthK.M., DomingoE., JonesA.M., BroderickP., et al. (2013). Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet, 45, 136–144.
15.
PelosiniC., MartinelliS., CeccariniG., MagnoS., BaroneI., BasoloA., et al. (2014). Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome. Metabolism, 63, 1385–1389.
16.
PrindleM.J., and LoebL.A. (2012). DNA polymerase delta in DNA replication and genome maintenance. Environ Mol Mutagen, 53, 666–682.
17.
RagnauthC.D., WarrenD.T., LiuY., McNairR., TajsicT., FiggN., et al. (2010). Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation, 121, 2200–2210.
18.
ReinierF., ZoledziewskaM., HannaD., SmithJ.D., ValentiniM., ZaraI., et al. (2015). Mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome in the context of inherited lipodystrophies. Metabolism, 64, 1530–1540.
19.
SasakiH., YanagiK., UgiS., KobayashiK., OhkuboK., TajiriY., et al. (2018). Definitive diagnosis of mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome caused by a recurrent de novo mutation in the POLD1 gene. Endocr J, 65, 227–238.
20.
ScaffidiP., and MisteliT. (2006). LaminA-dependent nuclear defects in human aging. Science, 312, 1059–1063.
21.
SempleR.K., SavageD.B., CochranE.K., GordenP., and O'RahillyS. (2011). Genetic syndromes of severe insulin resistance. Endocr Rev, 32, 498–514.
22.
ShastryS., SimhaV., GodboleK., SbracciaP., MelanconS., YajnikC.S., et al. (2010). A novel syndrome of mandibular hypoplasia, deafness, and progeroid features associated with lipodystrophy, undescended testes, and male hypogonadism. J Clin Endocrinol Metab, 95, E192–E197.
23.
SongJ., HongP., LiuC., ZhangY., WangJ., and WangP. (2015). Human POLD1 modulates cell cycle progression and DNA damage repair. BMC Biochem, 16, 14.
24.
SuX., YaoX., SunZ., HanQ., and ZhaoR.C. (2016). Optimization of reference genes for normalization of reverse transcription quantitative real-time polymerase chain reaction results in senescence study of mesenchymal stem cells. Stem Cells Dev, 25, 1355–1365.
25.
TakahashiY., MoriwakiS., SugiyamaY., EndoY., YamazakiK., MoriT., et al. (2005). Decreased gene expression responsible for post-ultraviolet DNA repair synthesis in aging: a possible mechanism of age-related reduction in DNA repair capacity. J Invest Dermatol, 124, 435–442.
26.
WangJ.L., GuoH.L., WangP.C., and LiuC.G. (2012). Age-dependent down-regulation of DNA polymerase δ1 in human lymphocytes. Mol Cell Biochem, 371, 157–163.
27.
WeedonM.N., EllardS., PrindleM.J., CaswellR., Lango AllenH., OramR., et al. (2013). An inframe deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nat Genet, 45, 947–950.
